enGene Therapeutics Inc.

Biological Products, (No Diagnostic Substances) | SIC: 2836
Phone: (514) 332-4888
CIK: 0001980845
State of Inc.: Z4
Tickers:
  • Nasdaq:ENGN
  • Nasdaq:ENGNW

Form: 4

Filing Date: 03 Feb 2026
Report Date: 30 Jan 2026
Accepted: 03 Feb 2026 02:13 p.m.
Accession Number: 0000929638-26-000484
Act: None
File Number: None
Film Number: None

Documents

Primary Document
Accepted: 03 Feb 2026 02:13 p.m.